Regeneron CEO Leonard Schleifer and CSO George Yancopoulos Named EY 2016 National Life Sciences Entrepreneurs Of The Year
Monday, November 21, 2016
Source: Yahoo! Finance
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Leonard Schleifer, M.D., Ph.D., Founder, President and Chief Executive Officer, and George Yancopoulos, M.D., Ph.D., Founding Scientist, President of Regeneron Laboratories and Chief Scientific Officer, have been named the EY (Ernst & Young) Entrepreneurs Of The Year® 2016 National Award Winners in the Life Sciences category.
The EY Entrepreneur Of The Year Award, a leading business award for entrepreneurs, recognizes leaders and visionaries who demonstrate innovation, financial success and personal commitment as they create and build world-class businesses. A panel of independent judges selected Drs. Schleifer and Yancopoulos from more than 250 regional award recipients.
"Under Len and George's leadership, Regeneron has grown from a tiny start-up into a leading biotechnology company," said P. Roy Vagelos, M.D., Chairman of the Regeneron Board of Directors. "Even now, as the company has grown to over 5,000 employees, Len and George continue to lead with a fierce entrepreneurial spirit and a willingness to do things differently. This spirit has enabled the Regeneron team to bring important medicines to people in need and to advance a promising pipeline of therapies for serious diseases."
To view the full list of this year's winners, please visit: